Invitae Corporation (0JDB.L) LSE
0.00
-0.0013(-72.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Invitae Corporation
Address
1400 16th Street
San Francisco, CA 94103
United States of America (the)
Phone
415 374 7782
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
1700
First IPO Date
January 29, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Kenneth D. Knight | President, Chief Executive Officer & Director | 1.4M | 1961 |
| Randal W. Scott | Co-Founder & Chairman of the Board | 50,000 | 1958 |
| Shelly D. Guyer | Chief Sustainability Officer | 430,444 | 1960 |
| W. Michael Korn | Chief Medical Officer | 751,951 | N/A |
| Thomas R. Brida | General Counsel, Chief Compliance Officer & Secretary | 776,722 | 1971 |
| Robert Guigley | Chief Commercial Officer | 0 | N/A |
| Hoki Luk | Head of Investor Relations and Capital Markets & Corporate Development | 0 | 1976 |
| David Sholehvar | Chief Operating Officer | 0 | 1968 |
| Ana J. Schrank | Chief Accounting Officer & Chief Financial Officer | 0 | 1966 |
| Desarie French | Chief Talent Officer | 0 | N/A |
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
